Suppr超能文献

铜绿假单胞菌拓扑异构酶IV的克隆、表达及酶学特性分析

Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV.

作者信息

Akasaka T, Onodera Y, Tanaka M, Sato K

机构信息

New Product Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.

出版信息

Antimicrob Agents Chemother. 1999 Mar;43(3):530-6. doi: 10.1128/AAC.43.3.530.

Abstract

The topoisomerase IV subunit A gene, parC homolog, has been cloned and sequenced from Pseudomonas aeruginosa PAO1, with cDNA encoding the N-terminal region of Escherichia coli parC used as a probe. The homolog and its upstream gene were presumed to be parC and parE through sequence homology with the parC and parE genes of other organisms. The deduced amino acid sequence of ParC and ParE showed 33 and 32% identity with that of the P. aeruginosa DNA gyrase subunits, GyrA and GyrB, respectively, and 69 and 75% identity with that of E. coli ParC and ParE, respectively. The putative ParC and ParE proteins were overexpressed and separately purified by use of a fusion system with a maltose-binding protein, and their enzymatic properties were examined. The reconstituted enzyme had ATP-dependent decatenation activity, which is the main catalytic activity of bacterial topoisomerase IV, and relaxing activities but had no supercoiling activity. So, the cloned genes were identified as P. aeruginosa topoisomerase IV genes. The inhibitory effects of quinolones on the activities of topoisomerase IV and DNA gyrase were compared. The 50% inhibitory concentrations of quinolones for the decatenation activity of topoisomerase IV were from five to eight times higher than those for the supercoiling activities of P. aeruginosa DNA gyrase. These results confirmed that topoisomerase IV is less sensitive to fluoroquinolones than is DNA gyrase and may be a secondary target of new quinolones in wild-type P. aeruginosa.

摘要

从铜绿假单胞菌PAO1中克隆并测序了拓扑异构酶IV亚基A基因(parC同源物),以编码大肠杆菌parC N端区域的cDNA作为探针。通过与其他生物的parC和parE基因的序列同源性,推测该同源物及其上游基因分别为parC和parE。推导的ParC和ParE氨基酸序列与铜绿假单胞菌DNA促旋酶亚基GyrA和GyrB的氨基酸序列分别具有33%和32%的同一性,与大肠杆菌ParC和ParE的氨基酸序列分别具有69%和75%的同一性。使用与麦芽糖结合蛋白的融合系统对推定的ParC和ParE蛋白进行了过表达和单独纯化,并检测了它们的酶学性质。重组酶具有ATP依赖性解连环活性,这是细菌拓扑异构酶IV的主要催化活性,还具有松弛活性,但没有超螺旋活性。因此,克隆的基因被鉴定为铜绿假单胞菌拓扑异构酶IV基因。比较了喹诺酮类药物对拓扑异构酶IV和DNA促旋酶活性的抑制作用。喹诺酮类药物对拓扑异构酶IV解连环活性的50%抑制浓度比对铜绿假单胞菌DNA促旋酶超螺旋活性的抑制浓度高五至八倍。这些结果证实,拓扑异构酶IV对氟喹诺酮类药物的敏感性低于DNA促旋酶,并且可能是野生型铜绿假单胞菌中新喹诺酮类药物的次要靶点。

相似文献

1
Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV.
Antimicrob Agents Chemother. 1999 Mar;43(3):530-6. doi: 10.1128/AAC.43.3.530.
5
Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
Antimicrob Agents Chemother. 1996 Sep;40(9):2054-61. doi: 10.1128/AAC.40.9.2054.
6
Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
Mol Microbiol. 1994 Aug;13(4):641-53. doi: 10.1111/j.1365-2958.1994.tb00458.x.
9
Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.
Antimicrob Agents Chemother. 1994 Nov;38(11):2623-7. doi: 10.1128/AAC.38.11.2623.

引用本文的文献

1
The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
Braz J Microbiol. 2016 Oct-Dec;47(4):925-930. doi: 10.1016/j.bjm.2016.07.016. Epub 2016 Jul 26.
2
Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa.
PLoS One. 2012;7(8):e42973. doi: 10.1371/journal.pone.0042973. Epub 2012 Aug 8.
3
Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.
Antimicrob Agents Chemother. 2003 Jun;47(6):1887-94. doi: 10.1128/AAC.47.6.1887-1894.2003.
4
DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis.
Antimicrob Agents Chemother. 2002 Aug;46(8):2582-7. doi: 10.1128/AAC.46.8.2582-2587.2002.

本文引用的文献

2
Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.
Antimicrob Agents Chemother. 1997 Nov;41(11):2362-6. doi: 10.1128/AAC.41.11.2362.
3
Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1997 Oct;41(10):2289-91. doi: 10.1128/AAC.41.10.2289.
4
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. doi: 10.1128/mmbr.61.3.377-392.1997.
5
Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
Antimicrob Agents Chemother. 1996 Dec;40(12):2714-20. doi: 10.1128/AAC.40.12.2714.
6
DNA gyrase as a drug target.
Trends Microbiol. 1997 Mar;5(3):102-9. doi: 10.1016/S0966-842X(96)10085-8.
7
Bacterial diversity based on type II DNA topoisomerase genes.
Annu Rev Genet. 1996;30:79-107. doi: 10.1146/annurev.genet.30.1.79.
8
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
Antimicrob Agents Chemother. 1996 Mar;40(3):710-14. doi: 10.1128/AAC.40.3.710.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验